Plasma Levels and Clinical Significance of Cytokine Profile in Patients with Multiple Myeloma.
10.19746/j.cnki.issn.1009-2137.2022.05.024
- Author:
Jun GAN
1
;
Bao-Guo CHEN
1
;
Ying ZHANG
1
;
Xue-Jiao CHEN
2
Author Information
1. Central Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, Zhejiang Province, China.
2. Central Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, Zhejiang Province, China,E-mail: chenxj@enzemed.com.
- Publication Type:Journal Article
- Keywords:
CD117;
CD56;
IL-6;
cytokines;
multiple myeloma
- MeSH:
Cytokines;
Humans;
Interleukin-10;
Interleukin-2;
Interleukin-4;
Interleukin-6;
Multiple Myeloma/diagnosis*;
Retrospective Studies;
Tumor Necrosis Factor-alpha
- From:
Journal of Experimental Hematology
2022;30(5):1464-1468
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the levels of cytokines in the plasma of patients with multiple myeloma(MM), and explore its clinical significance.
METHODS:The levels of 6 cytokines(IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ) in the plasma of 59 newly diagnosed MM patients and 30 healthy controls were retrospectively analyzed, and the immunophenotypes were also analyzed. The plasma levels of IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ were quantitatively detected by flow microsphere technology, and the differences of cytokines levels in each group were tested by Wilcoxon.
RESULTS:The plasma concentration of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ in MM patients were all significantly higher than those in healthy controls (P<0.05). According to the ISS staging, there were no statistically significant difference in cytokines levels of patients at each stage (P>0.05). MM patients with high CD56 expression had higher plasma levels of IL-6 than the CD56 low expression group (41.74±62.73 vs 6.31±5.60 pg/ml) (P<0.05). The plasma level of IL-6 in MM patients with high CD117 expression was higher than that in the CD56 low expression group, but there was no statistically difference (P>0.05). The plasma level of IL-6 in MM patients was significantly decreased after chemotherapy (P<0.05).
CONCLUSION:IL-6 is significantly increased in newly diagnosed MM patients, and is associated with the CD56 expression of abnormal plasma cells, which could provide important auxiliary effect on diagnosis of MM; at the same time, it is significantly decreased after chemotherapy, which may be suitable as a monitoring indicator in treatment of MM patients.
